Moomoo AI 已提取核心信息
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
Todd Franklin Watanabe, associated with Arcutis Biotherapeutics, Inc. [ARQT], reported multiple acquisitions of common stock on February 13, 2024. The transactions, described as grants, awards, or other acquisitions, resulted in a total direct acquisition of 216,882 shares. Following these transactions, Watanabe's direct holdings in the company amounted to 891,901 shares. Additionally, indirect holdings through trusts and an LLC totaled 231,140 shares, with the largest single indirect holding being 124,956 shares by a trust.
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的渡边托德·富兰克林于2024年2月13日报告了对普通股的多次收购。这些交易被描述为赠款、奖励或其他收购，共直接收购了216,882股股票。在这些交易之后，渡边在公司的直接持股量为891,901股。此外，通过信托和有限责任公司间接持有的股票共计231,140股，其中最大的单一间接持股为信托124,956股。
与Arcutis Biotherapeutics, Inc. [ARQT] 相关的渡边托德·富兰克林于2024年2月13日报告了对普通股的多次收购。这些交易被描述为赠款、奖励或其他收购，共直接收购了216,882股股票。在这些交易之后，渡边在公司的直接持股量为891,901股。此外，通过信托和有限责任公司间接持有的股票共计231,140股，其中最大的单一间接持股为信托124,956股。
有用
没用